Stereotaxis Accelerates Growth with Triple Milestone Achievement

Financial Performance Exceeds Expectations

Stereotaxis has announced three significant developments that signal a powerful acceleration phase for the robotics-assisted surgery specialist. The company has commenced the U.S. commercial rollout of its groundbreaking MAGiC Sweep catheter, delivered exceptionally strong quarterly financial results, and secured a substantial $50 million strategic financing arrangement with Roth Capital Partners.

The company’s second-quarter 2025 financial report demonstrated remarkable momentum. Revenue reached $8.8 million, representing a 95% increase compared to the same period last year and an 18% sequential improvement over the previous quarter. This performance substantially exceeded analyst projections of $7.75 million.